Biography
Dr. David Henderson is Associate Professor of Psychiatry at Harvard Medical School and Associate Psychiatrist at the Massachusetts General Hospital. He is the Director of the MGH Schizophrenia Diabetes and Weight Reduction Research and Associate Director of the MGH Schizophrenia Program. He serves also as the Medical Director for the Harvard Program in Refugee Trauma at MGH and the Associate Director of the MGH International Division in Psychiatry.
Dr. Henderson’s main research interests focus on psychopharmacological and antipsychotic agents in the treatment of schizophrenia, impacts of antipsychotic agents on metabolic anomalies, glucose metabolism, and weight, and ethnic and cultural impacts on psychiatry. He also studies the impact of trauma in areas of mass violence and develops programs to assist vulnerable populations which include projects in Rwanda, Cambodia, East Timor, Bosnia, Peru, New Orleans, and New York City. Dr. Henderson has published in journals such as the Archives of General Psychiatry, American Journal of Psychiatry, British Journal of Psychiatry and Biological Psychiatry. He has lectured extensively throughout the United States and internationally on schizophrenia, treatment-resistant schizophrenia, metabolic disorders and schizophrenia, psychopharmacology, ethnopsychopharmacology, trauma, and cultural psychiatry.
Disclosure
Research Support:
Johnson and Johnson/Ortho McNeil
Advisory/Consulting
NuPathe
Alkermes
Last updated: 5/1/2012
Courses
Schizophrenia: Critical Management Issues in First-Episode and Chronic Patients
Web Simulcast of Schizophrenia Critical Management Issues in First-Episode and Chronic Patients
Approaches to the Treatment Resistant Patient & Managing Medical Comorbidity
Long Term Management of Psychosis: Keys to Successful Maintenance Treatment and Relapse Prevention
Long Term Management of Psychosis and Optimal Care of Depression
Identifying and Managing Antipsychotic-Induced Metabolic Effects
Interactive Learning Module: Identifying and Managing Antipsychotic-Induced Metabolic Effects
Clinical Simulation: Identifying and Managing Antipsychotic-Induced Metabolic Effects
